Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Apr 2;19(7):e202400038.
doi: 10.1002/asia.202400038. Epub 2024 Feb 29.

Current Development of Lanthanide Complexes for Biomedical Applications

Affiliations
Review

Current Development of Lanthanide Complexes for Biomedical Applications

Mengfei Wang et al. Chem Asian J. .

Abstract

Luminescent molecule-based bioimaging system is widely used for precise localization and distinction of cancer/tumor cells. Luminescent lanthanide (Ln(III)) complexes offer long-lived (sub-millisecond time scale) and sharp (FWHM <10 nm) emission, arising from the forbidden 4f-4f electronic transitions. Luminescent Ln(III) complex-based bioimaging has emerged as a promising option for both in vitro and in vivo visualizations. In this mini-review, the historical development and recent significant progress of luminescent Ln(III) probes for bioapplications are introduced. The recent studies are mainly focused on three points: (i) the structural modifications of Ln(III) complexes in both macrocyclic and small ligands, (ii) the acquirement of high resolution luminescence images of cancer/tumor cells and (iii) the constructions of ratiometric biosensors. Furthermore, our recent study is explained as a new Cancer GPS (cancer grade probing for determining tumor grade through photophysical property analyses of intracellular Eu(III) complex.

Keywords: Bioimaging; Biosensing; Coordination chemistry; Lanthanide complexes; luminescence properties.

PubMed Disclaimer

References

    1. R. L. Siegel, K. D. Miller, N. S. Wagle, A. Jemal, Ca-Cancer J. Clin. 2023, 73, 17.
    1. D. C. Sullivan, Radiology 2000, 215, 634.
    1. C. M. C. Tempany, B. J. McNeil, Jama 2001, 285, 562.
    1. J. C. Richardson, R. W. Bowtell, K. Mäder, C. D. Melia, Adv. Drug Delivery Rev. 2005, 57, 1191.
    1. M. R. Whitson, P. H. Mayo, Crit Care 2016, 20, 227.

LinkOut - more resources